Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes
See our feature article, FDA Panel Approves Inhaled Insulin, Again.
Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes
Apr 3, 20142,056 views
Home / KEEP BUT DO NOT DISPLAY / Alerts / Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes
|
|
|
|